Ning Lin, Chen Di, Han Jie, Xie Guanyue, Sun Jianguang
The First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China.
Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Department of Hepatobiliary Medicine, Jinan, China.
Front Oncol. 2024 Dec 11;14:1474496. doi: 10.3389/fonc.2024.1474496. eCollection 2024.
Since the emergence of the hot topic of "ferroptosis," numerous studies have explored its role in hepatocellular carcinoma (HCC), revealing its significance in the disease's pathogenesis, progression, and treatment. However, there remains a significant gap in the quantitative analysis of ferroptosis in HCC. Therefore, this study aims to comprehensively assess the research progress and evolution in this field through bibliometric and citation analysis.
On June 27, 2024, the author conducted a literature search, extracting relevant publications from the Web of Science Core Collection (WOSCC) Science Citation Index Expanded (SCIE) spanning from January 2010 to December 2023. Subsequently, the compiled documents were subjected to bibliometric evaluation and analysis using visualization tools such as R package "bibliometrix", CiteSpace and VOSviewer.
The search yielded 576 papers by 3,925 authors, encompassing contributions from 34 countries and 685 institutions, published across 250 journals, including 25,889 co-cited references from 2,600 journals. Notably, China leads with a significant publication count of 481 articles (accounting for 83.5%) and demonstrates the strongest collaboration with the United States. The multifaceted role of ferroptosis in hepatocellular carcinoma (HCC) has garnered considerable attention. In recent years, research into disease prognosis, the tumor microenvironment, and targeted therapies involving immunology has become key themes and emerging frontiers in this field.
This study meticulously compiled and analyzed the current discourse and emerging perspectives on ferroptosis in HCC. Identifying research trends and hotspots offers valuable guidance for future investigations and provides a basis for the development of novel therapeutic strategies to improve HCC prognosis and treatment outcomes.
自“铁死亡”这一热门话题出现以来,众多研究探讨了其在肝细胞癌(HCC)中的作用,揭示了其在该疾病发病机制、进展和治疗中的重要性。然而,肝细胞癌中铁死亡的定量分析仍存在显著差距。因此,本研究旨在通过文献计量和引文分析全面评估该领域的研究进展与演变。
2024年6月27日,作者进行了文献检索,从Web of Science核心合集(WOSCC)科学引文索引扩展版(SCIE)中提取了2010年1月至2023年12月期间的相关出版物。随后,使用R包“bibliometrix”、CiteSpace和VOSviewer等可视化工具对汇编的文献进行文献计量评估和分析。
检索共得到3925位作者发表的576篇论文,涵盖来自34个国家和685个机构的贡献,发表在250种期刊上,包括来自2600种期刊的25889条共被引参考文献。值得注意的是,中国以481篇文章的显著发表数量领先(占83.5%),并与美国展现出最强的合作。铁死亡在肝细胞癌(HCC)中的多方面作用已引起相当大的关注。近年来,对疾病预后、肿瘤微环境以及涉及免疫学的靶向治疗的研究已成为该领域的关键主题和新兴前沿。
本研究精心汇编并分析了当前关于肝细胞癌中铁死亡的论述和新出现的观点。确定研究趋势和热点为未来研究提供了有价值的指导,并为开发改善肝细胞癌预后和治疗结果的新治疗策略提供了依据。